- Lobbying
- Lobbying by Biogen, Inc.
Lobbying Relationship
Bills mentioned
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Ann Jablon | Chief of Staff, Rep. Richard Neal. Chief of Staff, Rep. Richard E. Neal; Legislative Director, Rep. Richard E. Neal; Administrative Assistant, Rep. Richard E. Neal; Executive/ Legislative Assistant, Rep. Richard E. Neal. |
Aaron Cohen | Chief of Staff & Legislative Assistant, Sen. John Ensign; Legislative Aide, Sen. Richard Bryan; Legislative Corresp., Sen. Richard Bryan. |
Caitlin Shannon | Deputy Chief of Staff, Rep. Devin Nunes. |
Caitlin Canter | Deputy Chief of Staff, Rep. Devin Nunes. Deputy Chief of Staff, Rep. Devin Nunes; Legislative Assistant, Rep. Devin Nunes; Legislative Aide, Rep. Devin Nunes; Staff Assistant, Rep. Devin Nunes; Intern, Rep. Devin Nunes. |
Jeffrey Carroll | Staff Director House Energy and Commerce Committee; Chief of Staff, Rep. Frank Pallone; Legislative Director, Rep. Frank Pallone; Legislative Assistant, Rep. Frank Pallone. |
Jonathan Kott | Sr. Advisor & Communications Dir., Sen. Joe Manchin; Sr. Advisor & Communications Dir., Sen. Chris Coons; Press Sec., Rep. Brad Ellsworth; Press Sec., Rep. Anthony Weiner; Speechwriter, Sen. Evan Bayh; Public Affrs. Spec., Ofc. of the Director, OPM. |
Denise Henry Morrisey | n/a |
Shannon Finley | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Medicare beneficiary and patient access to treatments for Alzheimers disease, ALS, and other neurological conditions..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate